US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
Watchlist
36.570
+0.580+1.61% Close 12/01 16:00 ET
36.590+0.020+0.05%
Pre 07:20 ET
36.590High35.985Low2.55MVolume
36.030Open35.990Pre Close92.63MTurnover0.13%Turnover Ratio10.32P/E (TTM)75.24BMarket Cap37.83352wk High4.12P/E (Static)2.06BShares32.22552wk Low4.64P/B72.87BFloat Cap44.814Historical High1.39Dividend TTM1.99BShs Float6.631Historical Low3.80%Div YieldTTM1.68%Amplitude36.364Avg Price1Lot Size
GlaxoSmithKline Key Stats
Quarterly+Annual
YOY
| (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | (Q2)2022/06/30 | (Q1)2022/03/31 | (FY)2021/12/31 | (Q4)2021/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 96.92%1.53B | 133.91%1.75B | -7.91%1.63B | 39.96%4.92B | 286.90%1.63B | -17.65%779M | -16.18%746M | 40.56%1.77B | -31.10%3.52B | 194.17%420M |
| Deferred tax | 10.30%257M | 61.33%242M | -14.55%276M | 751.81%707M | 100.85%1M | -5.28%233M | 149.34%150M | 25.19%323M | 23.88%83M | 77.97%-117M |
| Other non cash items | -11.24%158M | -16.94%152M | -12.12%174M | -41.86%350M | -697.14%-209M | -6.32%178M | -1.61%183M | 3.66%198M | -49.92%602M | -94.05%35M |
| Change In working capital | 137.61%164M | -903.63%-1.99B | -75.37%-840M | -80.53%270M | -63.82%937M | -10.66%-436M | 191.85%248M | 11.13%-479M | -36.72%1.39B | -28.77%2.59B |
| -Change in receivables | ---- | ---- | ---- | 46.99%-616M | ---- | ---- | ---- | ---- | -85.03%-1.16B | ---- |
| -Change in inventory | ---- | ---- | ---- | -627.45%-269M | ---- | ---- | ---- | ---- | -49.00%51M | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | 53.15%1.63B | ---- | ---- | ---- | ---- | -16.63%1.06B | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 67.45%2.21B | -20.06%1.31B | -97.92%53M | -6.90%7.4B | -49.43%1.91B | -48.44%1.32B | 26.55%1.64B | 667.98%2.54B | -5.79%7.95B | -2.28%3.77B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -7.46%-288M | -23.63%-293M | -20.86%-226M | -21.88%-997M | 15.28%-305M | -33.33%-268M | -154.84%-237M | -14.02%-187M | 12.98%-818M | -36.88%-360M |
| Net intangibles purchase and sale | -115.22%-198M | -8.96%-231M | 21.51%-292M | 13.55%-919M | -320.91%-243M | 90.12%-92M | 49.16%-212M | -312.57%-372M | -73.41%-1.06B | 119.37%110M |
| Net business purchase and sale | 97.56%-73M | -632.43%-542M | 25.71%-52M | -1,795.14%-3.14B | 81.82%-6M | -8,682.35%-2.99B | -121.96%-74M | 17.65%-70M | -93.51%185M | 13.16%-33M |
| Net investment purchase and sale | ---- | ---- | ---- | -94.44%1M | --1M | ---- | ---- | ---- | 1,900.00%18M | --0 |
| Net other investing changes | ---- | ---- | ---- | -3,007.38%-3.79B | 89.74%-8M | -3,571.43%-771M | ---40M | ---2.97B | -115.14%-122M | ---78M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 88.01%-491M | -76.88%-964M | 88.64%-408M | -393.64%-8.77B | -49.58%-540M | -246.07%-4.09B | -194.59%-545M | -7,385.42%-3.59B | -182.23%-1.78B | -594.23%-361M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 9.30%-1.04B | 136.79%1.04B | 263.86%408M | -130.75%-4.62B | 71.49%-406M | -411.56%-1.15B | -706.88%-2.82B | -4,880.00%-249M | 50.35%-2B | -162.25%-1.42B |
| Net common stock issuance | --0 | -57.14%3M | -40.00%6M | 19.05%25M | --0 | 700.00%8M | 75.00%7M | -33.33%10M | -27.59%21M | 0.00%1M |
| Cash dividends paid | 19.57%-567M | 51.82%-557M | 41.70%-555M | 13.30%-3.47B | 31.23%-654M | 25.87%-705M | -0.43%-1.16B | -0.63%-952M | -0.55%-4B | -0.53%-951M |
| Net other financing activities | -100.94%-8M | 421.05%61M | -98.61%130M | 2,613.94%10.46B | 12,600.00%250M | 1,300.00%852M | 93.29%-19M | 15,725.00%9.38B | 38.37%-416M | 99.78%-2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -32.88%-1.76B | 100.69%31M | -103.99%-318M | 110.84%823M | 51.77%-1.34B | 4.88%-1.33B | -119.36%-4.49B | 679.43%7.97B | 25.10%-7.59B | -27.54%-2.77B |
| Net cash flow | ||||||||||
| Beginning cash position | -59.09%3.04B | -74.69%2.72B | -10.27%3.43B | -27.42%3.82B | 4.95%3.35B | 132.35%7.43B | 160.06%10.75B | -27.46%3.82B | 8.92%5.26B | -12.64%3.19B |
| Current changes in cash | 99.00%-41M | 111.01%374M | -109.72%-673M | 61.39%-546M | -95.73%27M | -27,226.67%-4.1B | -262.05%-3.4B | 733.30%6.92B | -400.85%-1.41B | -61.18%632M |
| Effect of exchange rate changes | 0.00%23M | -180.28%-57M | -358.33%-31M | 624.14%152M | 675.00%46M | 76.92%23M | 7,000.00%71M | 134.29%12M | 25.64%-29M | 63.64%-8M |
| End cash Position | -9.90%3.02B | -59.09%3.04B | -74.69%2.72B | -10.32%3.43B | -10.32%3.43B | 4.95%3.35B | 132.35%7.43B | 160.06%10.75B | -27.42%3.82B | -27.42%3.82B |
| Free cash flow | 103.92%1.72B | -34.47%772M | -124.14%-476M | -2.89%5.15B | -64.16%1.15B | -38.30%841M | 59.62%1.18B | 8,673.91%1.97B | -18.44%5.3B | -2.54%3.22B |
| Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--